B

BiohacksAI

Evidence-Based Biohacking

Patent Pending

Uroplakin Iii

164 PubMed studies analyzed · Evidence Score: 45.1

Research Domains

Uroplakin Iii has been studied across 10 research domains including 🔬 Oncology, 🫘 Kidney, 🧬 Hormones, ⏳ Longevity & Aging, 🦴 Bone & Joint. The primary research focus is 🔬 Oncology with 57% of studies addressing this area.

Loading evidence profile...

This evidence profile for Uroplakin Iii is generated deterministically from 164 PubMed-indexed studies. All data is corpus-verified with Merkle proofs. BiohacksAI does not provide medical advice. Always consult a healthcare professional before starting any supplement regimen.

Data source: PubMed/MEDLINE (NLM). Corpus version: v20260227-01. Patent pending (EVE-PAT-2026-001). © 2026 Organiq Sweden AB.